Maverick Nutrition Flow
Natural health product licensed in Canada
- Other names
- Flow, MN Flow w/ Cognigrape, Maverick Nutrition Flow w/ Cognigrape
- Licence holder
- Ensemble Opti Health Inc.
- NPN or DIN-HM
- 80094827
- Status
- Active licence
- Licence date
- 10 October 2019
- Revision date
- 28 October 2020
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Feuille Potency : 24 % Flavonoid glycosides | Not specified | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 25 mg | Not calculated |
| Centella asiatica Source : Feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1,000 mg | 50 mg | Not calculated |
| Acide 1H-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylique, 4,5-dihydro-4,5-dioxo- Source : Pyrroloquinoline quinone disodium salt | 5 mg | Not calculated |
| 1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piper nigrum - fruit | 2.85 mg | Not calculated |
| 1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piperine | 2.85 mg | Not calculated |
| Vitis vinifera Source : Fruit Extract : Matériel brut sec Extraction ratio : 37:1 Dry plant equivalent : 2,312.5 mg Potency : 0 3.20% - 4.80% Malvidin-3-glucoside | 62.5 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 1,250 mg Potency : 6 % Terpene lactones | 25 mg | Not calculated |
| Cynara cardunculus Source : Feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2,000 mg | 100 mg | Not calculated |
| L-alpha-Glycérophosphorylcholine Source : Alfoscérate de choline | 75 mg | Not calculated |
| Hericium erinaceus Source : Corps fructifère Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 500 mg Potency : 30 % Polysaccharides | 125 mg | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : N-acétyl L-chlorhydrate de carnitine | 125 g | Not calculated |
| Ribo-2,3,4,5-tétrahydroxyvaléraldéhyde, D- Source : Ribose | 100 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Cognigrape help to support/maintain attention and memory; aspects of cognitive functions. Cognigrape helps to support/maintain cognitive function in adults. Cognigrape help to support/maintain cognitive function in healthy adults. Source of antioxidants. Helps to enhance cognitive function and memory in adults. Helps support mitochondrial function. Helps to maintain and/or support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80094827
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging